研究者学術情報データベース

ウエシマ　サトシ
上島　智
UESHIMA SATOSHI

所属薬学部薬学科

職名准教授

論文
1.	2024/05	Potential treatment option of rivaroxaban for breastfeeding women: A case series │ Thrombosis Research │ 237,141-144頁 (共著)
2.	2024	Association of direct oral anticoagulant and delayed bleeding with pharmacokinetics after endoscopic submucosal dissection │ Gastrointestinal Endoscopy │ in press (共著)
3.	2024	Pharmacokinetic properties of CYP3A substrate midazolam associated with xenobiotic-mediated CYP induction in inflammation model mice │ BPB Reports │ in press (共著)
4.	2023/10	Attenuation of phenobarbital-induced cytochrome P450 expression in carbon tetrachloride-induced hepatitis in mice models │ Biopharmaceutics & Drug Disposition │ 44,351-357頁 (共著)
5.	2023/07	Decreased analgesic effect of tramadol in Japanese patients with CYP2D6 intermediate metabolizers after orthopedic surgery │ Biological and Pharmaceutical Bulletin │ 46 (7),907-913頁 (共著)
6.	2022/10	Changes in the expression of drug-metabolizing enzymes and drug transporters in mice with collagen antibody-induced arthritis │ Xenobiotica │ (共著)
7.	2022/07	臨床準備教育における治療薬物モニタリング（TDM）実習でのファーマコゲノミクス演習の教育効果 │ 薬学教育 │ (共著)
8.	2021/12	Urine volume to hydration volume ratio is associated with pharmacokinetics of high-dose methotrexate in patients with primary central nervous system lymphoma │ Pharmacology Research & Perspectives │ 9 (6),e00883 (共著)
9.	2021/11	High incidence of major bleeding with off-label use of edoxaban │ Journal of Clinical Biochemistry and Nutrition │ 69 (3),311-316頁 (共著)
10.	2021/10	Impact of silicone oil tamponade on intravitreally injected vancomycin pharmacokinetics in cynomolgus monkey eyes │ International Journal of Pharmaceutics │ 609,121185 (共著)
11.	2021/06	Incorrect holding angle of dry powder inhaler during the drug-loading step significantly decreases output efficiency │ Biological and Pharmaceutical Bulletin │ 44 (6),822-829頁 (共著)
12.	2021/03	Effects of antiepileptic drugs’ administration during pregnancy on the nerve cell proliferation and axonal outgrowth of human neuroblastoma SH-SY5Y nerve cells │ Biochemical and Biophysical Research Communications │ 554,151-157頁 (共著)
13.	2021/03	Pharmacokinetics of intravitreal vancomycin and ceftazidime in silicone oil-filled macaque eyes │ Translational Vision Science and Technology │ 10 (3),1 (共著)
14.	2020/02	Is “slow inhalation” always suitable for pressurized metered dose inhaler? │ AAPS PharmSciTech │ 21 (2),53 (共著)
15.	2019/10	Genetic variants of alcohol-metabolizing enzymes in Brugada syndrome: Insights into syncope after drinking alcohol. │ Journal of Arrhythmia │ 35 (5),752-759 (共著)
16.	2019/09	Population pharmacokinetics and pharmacodynamics of apixaban linking its plasma concentration to intrinsic activated coagulation factor X activity in Japanese patients with atrial fibrillation. │ The AAPS Journal │ 21 (5),80 (共著)
17.	2018/06	Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation. │ British Journal of Clinical Pharmacology │ 84 (6),1301-1312 (共著)
18.	2017/09	Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation. │ Pharmacogenetics and Genomics │ 27 (9),329-336 (共著)
19.	2017/06	抗てんかん薬TDM標準化ガイドライン (STATEMENT) 2017 Version 1.0 │ TDM研究 │ 34 (2),67-95 (共著)
20.	2017/06	心房細動患者におけるアピキサバンの血中濃度に及ぼす薬物動態関連遺伝子多型の影響 │ 臨床薬理の進歩 │ 38,104-112 (共著)
21.	2014/08	Interspecies comparison of hepatic metabolism of six newly synthesized retinoid X receptor agonistic compounds possessing a 6-[N-ethyl-N-(alkoxyisopropyl-phenyl)amino] nicotinic acid skeleton in rat and human liver microsomes. │ Drug Development and Industrial Pharmacy │ 40 (8),1065-1071 (共著)
22.	2013/04	多変量ロジスティック回帰分析を用いた腎機能障害患者における造影剤腎症の危険因子に関する研究 │ 日本注射薬臨床情報学会誌 │ 2 (1),19–28 (共著)
23.	2012/07	テイコプラニン初回投与設計における血中濃度予測の検討－性別，年齢別，血清クレアチニン値補正，BMI補正，eGFR推算式による影響－ │ 医療薬学 │ 38 (7),461–470 (共著)
24.	2012/03	肺癌患者におけるshort hydration法を用いたシスプラチン投与の安全性および忍容性 │ 医療薬学 │ 38 (3),184–190 (共著)
25.	2012/01	バンコマイシン初回投与および個別投与設計における日本人を対象とした新規 GFR 推算式の有用性 │ 薬学雑誌 │ 132 (1),125–133 (共著)
26.	2012/01	日本人を対象とした新規 eGFR 推算式を用いたバンコマイシン初回投与設計における血清クリアチニン値および BMI 値補正の有用性 │ 岡山県病院薬剤師会会報 │ 53 (1),18–22 (共著)
27.	2011/05	Therapy of febrile seizures in Scn1a mutant rats. │ Epilepsia │ 52 (5),1010–1017 (共著)
28.	2011/04	eGFR 推算式を用いたベイジアン法に基づくテイコプラニン血中濃度の予測精度評価 │ 岡山県病院薬剤師会会報 │ 52 (2),63–67 (共著)
29.	2011/01	Empirical approach for improved estimation of unbound serum concentrations of valproic acid in epileptic infants by considering their physical development. │ Biological and Pharmaceutical Bulletin │ 34 (1),108–113 (共著)
30.	2009/08	Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants. │ Journal of Clinical Pharmacy and Therapeutics │ 34 (4),415–422. (共著)
31.	2008/11	Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia. │ International Journal of Clinical Pharmacology and Therapeutics │ 46 (11),584–590 (共著)
32.	2008/10	注射用塩酸バンコマイシン製剤の先発品および後発品による腎機能低下事例の発生状況の比較 │ 薬学雑誌 │ 128 (10),1493–1498 (共著)
33.	2008/08	炭酸ナトリウム含有注射薬の溶解後の炭酸ガス発生による空気塞栓の問題点 │ 医療薬学 │ 34 (8),748–754. (共著)
34.	2008/05	薬物相互作用（12–ベンゾジアゼピン系睡眠薬の薬物相互作用) │ 岡山医学会雑誌 │ 120 (1),91–94 (共著)
35.	2008/02	Characterization of nonlinear relationship between total and unbound serum concentrations of valproic acid in epileptic children. │ Journal of Clinical Pharmacy and Therapeutics │ 33 (1),31–38 (共著)
36.	2007/09	薬物相互作用（10–免疫抑制薬の薬物相互作用 │ 岡山医学会雑誌 │ 119 (2),199–203 (共著)
37.	2007/01	薬物相互作用（8-抗てんかん薬の薬物相互作用) │ 岡山医学会雑誌 │ 118 (3),267–270 (共著)
38.	2006/06	ジゴキシン投与患児におけるジゴキシンの副作用と臨床検査値との関連性に関する検討 │ 日本病院薬剤師会雑誌 │ 42 (6),765–767 (共著)
39.	2006/05	薬物相互作用（6 - 抗うつ薬の薬物相互作用） │ 岡山医学会雑誌 │ 118 (1),67-72 (共著)